Thinking of joining a study?

Register your interest

NCT05723471 | Not yet recruiting | Cancer


Impact of a Collaborative Program of Physical Activity of Newly-diagnosed Cancer Patients
Sponsor:

University Hospital, Toulouse

Brief Summary:

During the last twenty years, the cancer overall incidence has been increasing in europe and developed countries, while diagnostic and therapeutic progress have contributes to a reduction in mortality. Currently, almost 4 million people are treated or followed for cancer in France. The physical, psychological and social after-effects are significant. Adaptated physical activity plays an important role in the rehabilitation process. Overall, meta-analyses carried-out with most frequent cancers demonstrate that physical activity practiced would allow an improvement in quality of life, tolerance to anticancer treatments and survival.

Condition or disease

Cancer

Intervention/treatment

Adaptive Physical Activity

Phase

Not Applicable

Detailed Description:

This is a multicenter, two-arm parallel-group randomizes (in a 1:1 ratio), open-label, controlled intervention clinical trial of the comparison of long term adherence to physical activity between an adaptative, customized and collaborative exercise program and standard exercise prescription in patients with newly diagnosed cancer.}}

Study Type : Interventional
Estimated Enrollment : 350 participants
Masking : None (Open Label)
Primary Purpose : Supportive Care
Official Title : Impact of a Collaborative Program of Customized, Adaptive and Supervised Physical Activity on Adherence, Fitness, Quality of Life and Resilience of Newly-diagnosed Cancer Patients
Actual Study Start Date : December 1, 2023
Estimated Primary Completion Date : October 31, 2027
Estimated Study Completion Date : December 31, 2027
Arm Intervention/treatment

Experimental: Adaptive Physical Activity

No Intervention: Standard Exercise

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • newly-diagnosed cancer patient
  • able to start a program of physical activity within the first year follow diagnosis
  • performance status between 0 to 2
Exclusion Criteria
  • uncontrolled cardiovascular disease
  • peripheral neuropathy grade 3-4 with risk of falling
  • bone metastasis with risk of bone fracture
  • platelets <100X109/L
  • hemoglobin <8g/dL
  • patient under legal protection

Impact of a Collaborative Program of Physical Activity of Newly-diagnosed Cancer Patients

Location Details


Please Choose a site



Impact of a Collaborative Program of Physical Activity of Newly-diagnosed Cancer Patients

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

France,

Stéphanie MOTTON

Toulouse, France, 31059

Loading...